225 related articles for article (PubMed ID: 34210822)
1. Diagnostic Value of the CSF α-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy Bodies.
Rossi M; Baiardi S; Teunissen CE; Quadalti C; van de Beek M; Mammana A; Stanzani-Maserati M; Van der Flier WM; Sambati L; Zenesini C; Caughey B; Capellari S; Lemstra AW; Parchi P
Neurology; 2021 Aug; 97(9):e930-e940. PubMed ID: 34210822
[TBL] [Abstract][Full Text] [Related]
2. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study.
Iranzo A; Fairfoul G; Ayudhaya ACN; Serradell M; Gelpi E; Vilaseca I; Sanchez-Valle R; Gaig C; Santamaria J; Tolosa E; Riha RL; Green AJE
Lancet Neurol; 2021 Mar; 20(3):203-212. PubMed ID: 33609478
[TBL] [Abstract][Full Text] [Related]
3. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies.
Rossi M; Candelise N; Baiardi S; Capellari S; Giannini G; Orrù CD; Antelmi E; Mammana A; Hughson AG; Calandra-Buonaura G; Ladogana A; Plazzi G; Cortelli P; Caughey B; Parchi P
Acta Neuropathol; 2020 Jul; 140(1):49-62. PubMed ID: 32342188
[TBL] [Abstract][Full Text] [Related]
4. Measurement of CSF α-synuclein improves early differential diagnosis of mild cognitive impairment due to Alzheimer's disease.
García-Ayllón MS; Monge-Argilés JA; Monge-García V; Navarrete F; Cortés-Gómez MA; Sánchez-Payá J; Manzanares J; Gasparini-Berenguer R; Leiva-Santana C; Sáez-Valero J
J Neurochem; 2019 Jul; 150(2):218-230. PubMed ID: 31077373
[TBL] [Abstract][Full Text] [Related]
5. Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodies.
Brockmann K; Quadalti C; Lerche S; Rossi M; Wurster I; Baiardi S; Roeben B; Mammana A; Zimmermann M; Hauser AK; Deuschle C; Schulte C; Waniek K; Lachmann I; Sjödin S; Brinkmalm A; Blennow K; Zetterberg H; Gasser T; Parchi P
Acta Neuropathol Commun; 2021 Oct; 9(1):175. PubMed ID: 34717775
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid α-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer's disease.
Mackin RS; Insel P; Zhang J; Mohlenhoff B; Galasko D; Weiner M; Mattsson N
J Alzheimers Dis; 2015; 43(3):1007-16. PubMed ID: 25125463
[TBL] [Abstract][Full Text] [Related]
7. α-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies.
Bongianni M; Ladogana A; Capaldi S; Klotz S; Baiardi S; Cagnin A; Perra D; Fiorini M; Poleggi A; Legname G; Cattaruzza T; Janes F; Tabaton M; Ghetti B; Monaco S; Kovacs GG; Parchi P; Pocchiari M; Zanusso G
Ann Clin Transl Neurol; 2019 Oct; 6(10):2120-2126. PubMed ID: 31599499
[TBL] [Abstract][Full Text] [Related]
8. Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis.
Peña-Bautista C; Kumar R; Baquero M; Johansson J; Cháfer-Pericás C; Abelein A; Ferreira D
Front Mol Biosci; 2023; 10():1193458. PubMed ID: 37266333
[No Abstract] [Full Text] [Related]
9. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies.
Bargar C; Wang W; Gunzler SA; LeFevre A; Wang Z; Lerner AJ; Singh N; Tatsuoka C; Appleby B; Zhu X; Xu R; Haroutunian V; Zou WQ; Ma J; Chen SG
Acta Neuropathol Commun; 2021 Apr; 9(1):62. PubMed ID: 33827706
[TBL] [Abstract][Full Text] [Related]
10. Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders.
Manne S; Kondru N; Hepker M; Jin H; Anantharam V; Lewis M; Huang X; Kanthasamy A; Kanthasamy AG
J Neuroimmune Pharmacol; 2019 Sep; 14(3):423-435. PubMed ID: 30706414
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Patients With Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease at 3 and 5 Years After Diagnosis.
Hamilton CA; Donaghy PC; Durcan R; Ciafone J; Olsen K; Roberts G; Firbank MJ; Allan LM; Taylor JP; O'Brien JT; Thomas AJ
Neurology; 2024 Jul; 103(2):e209499. PubMed ID: 38870460
[TBL] [Abstract][Full Text] [Related]
12. RT-QuIC Detection of Pathological α-Synuclein in Skin Punches of Patients with Lewy Body Disease.
Mammana A; Baiardi S; Quadalti C; Rossi M; Donadio V; Capellari S; Liguori R; Parchi P
Mov Disord; 2021 Sep; 36(9):2173-2177. PubMed ID: 34002890
[TBL] [Abstract][Full Text] [Related]
13. Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease.
Hall S; Orrù CD; Serrano GE; Galasko D; Hughson AG; Groveman BR; Adler CH; Beach TG; Caughey B; Hansson O
Acta Neuropathol Commun; 2022 Jun; 10(1):90. PubMed ID: 35733234
[TBL] [Abstract][Full Text] [Related]
14. The value of cerebrospinal fluid α-synuclein and the tau/α-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology.
Førland MG; Tysnes OB; Aarsland D; Maple-Grødem J; Pedersen KF; Alves G; Lange J
Eur J Neurol; 2020 Jan; 27(1):43-50. PubMed ID: 31293044
[TBL] [Abstract][Full Text] [Related]
15. Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression.
van de Beek M; van Steenoven I; van der Zande JJ; Barkhof F; Teunissen CE; van der Flier WM; Lemstra AW
Mov Disord; 2020 May; 35(5):859-867. PubMed ID: 32048343
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of EEG in prodromal dementia with Lewy bodies.
van der Zande JJ; Gouw AA; van Steenoven I; van de Beek M; Scheltens P; Stam CJ; Lemstra AW
Neurology; 2020 Aug; 95(6):e662-e670. PubMed ID: 32636325
[TBL] [Abstract][Full Text] [Related]
17. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
[TBL] [Abstract][Full Text] [Related]
18. Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden.
Bentivenga GM; Mammana A; Baiardi S; Rossi M; Ticca A; Magliocchetti F; Mastrangelo A; Poleggi A; Ladogana A; Capellari S; Parchi P
Acta Neuropathol; 2024 Jan; 147(1):18. PubMed ID: 38240849
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC.
Donadio V; Wang Z; Incensi A; Rizzo G; Fileccia E; Vacchiano V; Capellari S; Magnani M; Scaglione C; Stanzani Maserati M; Avoni P; Liguori R; Zou W
Neurology; 2021 May; 96(20):e2513-e2524. PubMed ID: 33837116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
